Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,824.81
(
0.62%
)
US TECH 100
24,401.40
(
0.65%
)
Dow Jones
48,193.02
(
0.59%
)
Brent Oil
94.80
(
-0.04%
)
Bitcoin
72,106.00
(
1.37%
)
News Focus
News Focus

Replies to post #252 on Opexa Therapeutics, Inc. (OPXA)

Replies to #252 on Opexa Therapeutics, Inc. (OPXA)
icon url

io_io

11/29/10 2:44 PM

#253 RE: tnzalu #252

I remain bullish and long.....

Me too. That was good news with both finolimod and cladribine getting pushed back by the regulators. Clearly the "right" MS drug has yet to be found.